Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
BridgeBio
Biotech
BridgeBio bags $250M in stock sale before acoramidis submission
BridgeBio has roped in a $250 million private placement, infusing the company with much-needed cash as it plans a commercial launch for acoramidis.
Gabrielle Masson
Sep 25, 2023 11:20am
BridgeBio heart disease med vindicated with phase 3 victory
Jul 17, 2023 10:12am
BridgeBio's phase 2 data provides hope for rare disease drug
Jun 14, 2022 8:20am
BridgeBio's CEO on staying alive, 'motherhood and apple pie'
May 26, 2022 5:00am
BridgeBio adds another $110M to coffers with voucher sale
May 13, 2022 9:45am
After layoffs, BridgeBio seeks partners for 6 drug candidates
May 6, 2022 10:05am